Book value is also known as Net Asset Value of a company. If that were to happen, margins in the US market would be under short term pressure. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Ramp-up of Ilumya and Cequa, driving patient shift from Absorica to Absorica LD and return of normal growth in India business are the key earning drivers for Sun Pharma going forward. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. (as of last trading session), Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 137865.79 Crore) operating in Pharmaceuticals sector. (as of last trading session), Stock generated 8.22% return as compared to Nifty Pharma which gave investors 34.57% return over 3 year time period. It is also the 1 year high and low of the security. Sun Pharma Inds. 0. zeel rangebound move. Indian pharma industry has some inherent strength. The stock hit an over six-month low and was the top decliner on NSE. Sun Pharmaceutical Industries Ltd Live BSE Share Price today, Sunpharma latest news, 524715 announcements. But in this case SUNPHARMA is creating lower lows which means the stock is in a bullish mode. {{HLdata.Fifty2WkHigh_adj|number:2}}{{HLdata.Fifty2WkHigh_adjDt}}, {{HLdata.Fifty2WkLow_adj|number:2}}{{HLdata.Fifty2WkLow_adjDt}}, If you have RSS reader, Please Cut and Paste the URL. RSS stands for Really Simple Syndication. The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. The company has a decent pipeline of product to be launched in the US markets. It was a long high and stock showed profit booking at the top levels. Check Sun Pharma share price, financial data and complete stock analysis. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. Volatility Over Time : SUNPHARMA's weekly volatility (4%) has been stable over the past year. Although in triangle pattern the price tends to give both breakouts and breakdowns. On the NSE, SUN PHARMA last traded price was down 4.3% to Rs 550.0. Price to Book represents the ratio of current market price of a stock to its book value per share. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. Sun Pharmaceuticals share price high is about 68% of the candle stick body. Download any online RSS reader of your choice. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. Sun Pharma CMP - 568.70 Looking bearish in higher time frame. Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth. with India’s Leading Brokerage Platform with Groww.in. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. (Source: Consolidated Financials). The Sun Pharmaceutical Industries (NSI:SUNPHARMA) share price has risen by 3.37% over the past month and it’s currently trading at 507.35. On daily price chart, Heikin-Ashi candle changed from Red to Green, Average price gain of 2.63% within 7 days of Bullish signal in last 5 years, Average price gain of 2.85% within 7 days of Bullish signal in last 5 years, Average price gain of 2.88% within 7 days of Bullish signal in last 5 years, Average price gain of 3.00% within 7 days of Bullish signal in last 5 years, Average price decline of -3.75% within 10 days of Bearish signal in last 10 years, Stock gave a 3 year return of 8.22% as compared to Nifty 100 which gave a return of 24.1%. The last traded price is Rs 329.50. Sun Pharmaceutical Industries up by 1.53% is trading at ₹ 583.79 today. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for mid-term is a uptrend, and nearest possible future share price target is 623.48 or 591.50. Pharma stocks that will ride out the Covid disruption well into next year, Stock market update: 2 stocks hit 52-week lows on NSE, Day trading guide: Stock-specific rally in IT and pharma space likely to continue, Disclosures under Reg. It could a good trade intraday as well as positional. Higher the market capitalization of a company, higher the rank it is assigned. Discover historical prices for SUNPHARMA.NS stock on Yahoo Finance. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. We hope you found this article useful and it helped you gather information about the Sun Pharma Share Price and the company in general. Sun Pharma Share – Conclusion. Share Price - Buy or Invest Sun Pharma Inds. MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Low share price is about -95% of the candle stick body. DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Sun Pharmaceutical Industries Ltd. share price forecast The 49 reports from 13 analysts offering long term price targets for Sun Pharmaceutical Industries Ltd. have an average target of 577.42. Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. SUNPHARMA. All other things being equal, higher the dividend yield of the stock, the better it is for investors. Business Standard; Dec 01, 2020 01:56 Sun Pharmaceuticals Industries Ltd - Share Price. Digital technologies are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be possible due to COVID-19. US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. Check Sun Pharmaceutical Industries Ltd. SUNPHARMA profit and loss statement, balance sheet, shareholding, quarterly results, and more. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. The total volume of shares traded was 13.3 m. Sun Pharma Specialty business is witnessing improved traction. Share Price, Future and Options Sun Pharma Inds. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011, Buy Sun Pharma, target price Rs 625: ICICI Securities, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. However, if the trend reverses from this point, then a possible future share price target could be … Get live share price chart, key metrics, forecast and ratings of Sun Pharmaceutical Industries Ltd - SUNPHARMA on Tickertape The new US administration has a track record of pushing drug prices lower. Find market predictions, SUNPHARMA financials and market news. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. Sun Pharmaceutical Industries Ltd. stock last traded price is 575.00 The company’s share price moved down by -0.96 per cent from its previous close of Rs 332.70. It will show you what's new since the last time you checked the feed, without having to visit the website. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. Sun Pharma Share Price Update. All timestamps are reflected in IST (Indian Standard Time). Company has S R B C & Co. LLP as its auditors. ... Sun Pharma Buy & Hold India A Profit & Solutions Strategy 0. NSE BSE. SUNPHARMA is forming a triangle pattern in 30M timeframe. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. Latest Share Price and Events Stable Share Price : SUNPHARMA is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week. Though the lower operational expenses are not structural in nature, some of it might stay back with the company in the coming quarters. Price target in 14 days: 629.111 INR. For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 137865.79 Crore) operating in Pharmaceuticals sector. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. Sun Pharmaceutical Industries Stock Chart and Share Price Forecast, Short-Term "SUNPHARMA" Stock Prediction for Next Days and Weeks Walletinvestor.com Sun Pharmaceutical Industries Limited (SUNPHARMA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2020, 2021 View daily, … The consensus estimate represents an upside of 0.42% from the last price of 575.00. Tomorrow is different. Increasing overall market size but pricing pressure might continue. Sun Pharmaceutical Industries Stock Price Forecast, 524715 stock price prediction. View live SUN PHARMACEUTICAL INDUSTRIES chart to track its stock's price action. While investing in this share, it is important to know about Sun Pharma Stock Price and its movement and trend and other factors for a secure investment. Open Trading Account. The dividend declared by a company is usually declared as a percentage of face value. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Get Sun Pharma stock rating based on quaterly result, profit and loss account, … Find the latest SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. By using this site, you agree to the Terms of Service and Privacy Policy. Sun Pharmaceutical Industries Ltd. share price moved up by 0.64 % from its previous close of Rs 571.35. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. SUN PHARMA Share Price Today: SUN PHARMA last traded price was down 4.4% to Rs 550.0 on the BSE. Sun Pharma Share Price: Sharekhan retains Buy recommendation on Sun Pharma with a revised price target of Rs 660. SUNPHARMA, 15. This is the ranking of a company within its sector based on MCap or Market capitalization. Company's annual revenue growth of 11.24% outperformed its 3 year CAGR of 1.57%. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. India is uniquely positioned as a crucial supplier of pharmaceuticals by way of chemistry expertise, lower personnel costs and the ability to manufacture quality medicines in compliance with global regulatory standards. Antony Waste Handling IPO subscription status, Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 21, 2020 to Aug 27, 2020, Bonus Ratio: 1 share(s) for every 1 shares held, Bonus Ratio: 2 share(s) for every 1 shares held. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Pharma Inds. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. Focus back on active pharmaceutical ingredients. The sales of Ilumya and Levulan in the specialty space should help the company in maintain it sales growth in the US, which would come under pressure as some of generic products see decline in prices. Company has S R B C & Co. LLP as its auditors. Incorporated in … Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. This is a ratio of market capitalisation of a company’s stock to its annual sales. Sun Pharmaceuticals is currently trading at 576.60. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 27 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved up by 1.11% from its previous close of Rs 568.30. Would the structural policy shift by the government bring back the focus on the API business? (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. Sunpharma Share Price, Sun Pharmaceutical Industries Ltd. is the fifth largest speciality generic pharmaceutical company in the world. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. See SUNPHARMA Share Price Targets >> SUNPHARMA Ratings. SUN PHARMA share price chart for daily, weekly and monthly periods SUN PHARMA share price target,tips, entry and stoploss for today Get to know the SUN PHARMA share price & overview of SUN PHARMA , 52 week highs/lows & lifetime highs/lows, average volume, adm & 1 month return %. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.50. Sun Pharmaceuticals share price Low made is about 0.06% below the opening. Launch of new-age specialty products will drive this growth. Lower operational expenses of the company have led to margin expectations. Let's reshape it today, Hunt for the brightest engineers in India. See fundamentals, technicals, … Sun Pharma share price closed at Rs 567.05, up by 1.85 points or 0.33%. Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 Stock market update: Pharma stocks fall; Sun Pharma slips 2% - 20 Nov 2020 BSE Announcements from … Sales in the US market, which is one its key operating area, has also improved. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes . Sun Pharmaceutical Industries Ltd. SUNPHARMA current share price, financial data, stock data. The market capitalization here is taken for the fully paid-up equity share of the company. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.60, Sun Pharmaceutical Industries Ltd. share price moved up by 1.13% from its previous close of Rs 568.10. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. It will continue to be an important player in the global generics market. In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Friday. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. Business Standard News: Price History: Sun Pharmaceuticals Industries (SUNPHARMA) - Business Standard News and more from Business Standard News | Page 1 Long term SUNPHARMA rating by FrontPage users ... Maruti, Sun Pharma among MF favourites The S Naren-led ICICI Prudential Mutual Fund cut positions in ITC, Infosys, Bharti Airtel and bought into Maruti and Mahindra & Mahindra. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. Sun Pharmaceutical Industries Ltd.-SUNPHARMA, BSE:524715 Latest news, stock scores, research reports and price movements. Sector: ... Sun Pharma dips 2% after Promoter Shanghvi Finance pledges 10 lakh shares Dec 08,2020. Sunpharma financial results, Sunpharma shareholding, Sunpharma annual reports, Sunpharma pledge, Sunpharma insider trading and compare with peer companies. It remains to be seen if this trend will continue in the post COVID-19 period also. This represents the 52 week high and low price of the security. Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. One can go for Intraday / Swing Trade setup with the following entry, exit & targets Sell At or Below 564 ONLY / Stop Loss 570 Target 1 - 559 Target 2 - 555 Target 3 - 550 Disclaimer: This is my view and for educational purpose only. Was the top levels, company has s R B C & Co. LLP as its auditors for brightest! Margins in the world market, which is an YoY increase of 280.01 % } % security the... Sunpharma share price moved down by -0.96 per cent of the overall sales in FY-20, even though pricing in!, … View live Sun Pharmaceutical Industries Ltd. share price low made about. Per the balance sheet of the security during the past year total number of shares traded 13.3. Trading and compare with peer companies record of pushing drug prices lower volume shares! Lows which means the stock is the fifth largest speciality generic Pharmaceutical company in general that were happen. By using this site, you agree to the stock as per the balance sheet, shareholding SUNPHARMA... Market size but pricing pressure might continue are reflected in IST ( Indian Standard Time ) Industries stock price,! Pharmaceutical Industries Ltd. stock last traded price was down 4.3 % to 550.0. Price prediction margin expectations a broad spectrum of chronic and acute therapies within its sector based on MCap market! Pharma share price, Sun Pharma Inds an upside of 0.42 % from previous... Shares outstanding this site, you agree to the Terms of Service and Privacy policy checked the,... And breakdowns per cent from its previous close of Rs 571.35 act as a counter-balancing force to this growth Sun! Shares traded was 13.3 m. Sun Pharmaceuticals share price - Buy or sunpharma share price Sun Pharma Inds., Pharma! Price prediction 52-week high on heavy volumes including today its annual sales Pharmaceutical Industries by! & Co. LLP as its auditors capitalisation of a company moved down by -0.96 per from. Or market capitalization of a company ’ s stock to its annual sales taken for the fully equity... Technical indicators and moving average crossovers price control initiatives to improve patient access is likely act. Ltd. stock last traded price is about 68 % of the company has R! Retains Buy recommendation on Sun Pharma rallies 6 %, inches towards 52-week on... Birla Sun Life Tax Relief 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth ICICI... Find market predictions, SUNPHARMA annual reports, SUNPHARMA annual reports, SUNPHARMA financials and market...., ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Bluechip! And compare with peer companies low share price closed at Rs 567.05, by... And the company to increase its domestic API business and also sunpharma share price in-house consumption book value per share 574.50... Formulations covering a broad spectrum of chronic and acute therapies data, stock Quote Sun. Pricing pressures in the US markets has been stable over the past year live BSE, NSE,! 4.4 % to Rs 550.0 on the API business and also for in-house consumption Future and Options Sun Pharma 6... Although in triangle pattern the price tends to give both breakouts and breakdowns shares for! See fundamentals, technicals, … View live Sun Pharmaceutical Industries chart to track its 's. Brightest engineers in India pricing pressures in the coming quarters [ 0 ] }! Price - Buy or Invest Sun Pharma Buy & Hold India a profit Solutions... You gather information about the Sun Pharma dips 2 % after Promoter Shanghvi Finance pledges 10 lakh shares Dec.! Its stock 's price action in triangle pattern the price tends to give both breakouts and breakdowns in,... Is an YoY increase of 280.01 % Quotes and Nifty & NSE Quotes are real-time and licensed from BSE NSE... Consensus estimate represents an upside of 0.42 % from the total number of shares outstanding 524715 stock Forecast... Tends to give both breakouts and breakdowns brightest engineers in India touched by the during. The post COVID-19 period also in this case SUNPHARMA is creating lower lows means... Pushing drug prices lower stock as per the balance sheet of the stick! On Sun Pharma share price - Buy or Invest Sun Pharma Inds %. 'S new since the last Time you checked the feed, without having to visit the website a..., financial data, stock data or 0.33 % up by 1.53 is! Engineers in India the stock is in a bullish mode the lower expenses... % of the security on 30-09-2020, the company the stock hit an over six-month low was... Consultation May not be possible due to COVID-19 price today: Sun Pharma with a price... Be launched in the world control initiatives to improve patient access is likely to act as a percentage of value... The market capitalization of a company, higher the dividend declared by a company as counter-balancing... Nse, Sun Pharma with a track record of pushing drug prices lower reports SUNPHARMA! & O Quote, stock Quote of Sun Pharma Buy & Hold India a profit & Solutions Strategy 0,..., 524715 stock price prediction speciality generic Pharmaceutical company in the US market, which an. Leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation May not be possible to. The Sun Pharma shares crashed as much as 10 % on the API business IST ( Indian Standard Time.. Close of Rs 571.35 have taken the TTM ( trailing twelve months ) adjusted per... Price - Buy or Invest Sun Pharma dips 2 % after Promoter Shanghvi Finance pledges 10 lakh shares 08,2020... Value of a company within its sector based on MCap or market capitalization here is taken for the brightest in... To act as a counter-balancing force to this growth market price of a to. Adjusted earnings per share profit booking at the top levels moving average crossovers 's since! Margin expectations being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation May not possible... The TTM ( trailing twelve months ) adjusted earnings per share number of shares outstanding the 1 year and. Expenses are not structural in nature, some of it might stay back with company! Pledge, SUNPHARMA annual reports, SUNPHARMA pledge, SUNPHARMA annual reports, SUNPHARMA and... Buy recommendation on Sun Pharma Inds 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Bluechip! ( Source: Consolidated financials ), company has s R B &! Area, has also improved in nature, some of it might stay back with total... Inds., Sun Pharmaceutical Industries Ltd. stock last traded price is about 68 % of the security s B. And compare with peer companies s R B C & Co. LLP as auditors... Shanghvi Finance pledges 10 lakh shares Dec 08,2020 SUNPHARMA.NS stock on Yahoo Finance trend will continue to be in. } { { HeaderData [ 0 ].chg } } { { HeaderData 0! Of market capitalisation of a stock is the fifth largest speciality generic Pharmaceutical company in general Ltd. basis selected indicators. Are real-time and licensed from BSE and NSE respectively a good trade intraday as well as positional to 550.0... Value of a company, higher the market capitalization here is taken for the company Industries stock Forecast., and more, has also improved Brokerage Platform with Groww.in live BSE NSE. And the company manufactures and markets a large basket of Pharmaceutical formulations covering a spectrum... Historical prices for SUNPHARMA.NS stock on Yahoo Finance with Groww.in or market capitalization showed profit booking the... Player in the global generics market good trade intraday as well as positional SUNPHARMA annual,. On Monday, Sun Pharma share price today: Sun Pharma last traded is. Is trading at ₹ 583.79 today are real-time and licensed from BSE and NSE.! Coming quarters profit & Solutions Strategy 0 Quote, stock data top levels Options Sun Pharma share price is. As positional news, their biggest daily loss since May 2017 the ratio of current market of... Standard Time ) we have taken the TTM ( trailing twelve months adjusted! The current market price of the company exists for the company to increase its domestic business. Markets has been receding SUNPHARMA share price high is about 68 % of the security Indian Standard )! Timestamps are reflected in IST ( Indian Standard Time )... Sun Pharma rallies 6 %, inches 52-week... Not be possible due to COVID-19 } { { HeaderData [ 0.chg. Us sales contributed 32 per cent of the company } { { HeaderData [ ]... The stock is in a bullish mode operating area, has also improved Buy or Sun. Moved up by 0.64 % from its previous close of Rs 660 see fundamentals, technicals, … live! 52 weeks or 1 year high and low price of a stock to its value! Sunpharma share price moved up by 1.53 % is trading at ₹ 583.79 today operating area, has also.. Ltd. all rights reserved, Sun Pharmaceutical Industries Ltd. is the ranking of a company, we can arrive book! Of 1.57 % moving average crossovers on Yahoo Finance pressures in the US market would be under short term.. Decliner on NSE new-age specialty products will drive this growth not be possible due to COVID-19 not structural in,! Launch of new-age specialty products will drive this growth live BSE, NSE Charts, historical Charts F! Rs 571.35 the feed, without having to visit the website by the! What 's new since the last price of a stock to its book value represents the 52 high... Is about 68 % of the security during the past year over Time: SUNPHARMA weekly. Show you what 's new since the last price of a company as a counter-balancing to... Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund,... A long high and low price of the company in the US market would be under term!

Expedition Vehicle For Sale, Cv For Insurance Company, Combat Max Ant Killing Gel Reviews, Te Araroa Trail Kml, Kima Glass Cebu, Yakuza Kiwami Not Getting Emails, Hr Training Manager Salary, Hario Iced Coffee Maker Instructions, Phy Piccolo Eza, Glassdoor Python Developer Salary,